Page 434 - The Vasculitides, Volume 1: General Considerations and Systemic Vasculitis

408 Index

I indentation, 36
India, 45, 73, 74, 82, 111, 263, 271, 360
IBD, 154 individuals, 31, 37, 43, 49, 148, 169, 182, 189, 203,
ICAM, 119, 184
Iceland, 359 205, 228, 232, 234, 237, 262, 263, 264, 268, 275,
ID, 61, 295 284, 312, 338, 387
ideal, 269, 270 indolent, 234, 387, 396
identification, 17, 25, 95, 100, 101, 106, 155, 236, inducer, 314
induction, 29, 33, 43, 48, 53, 61, 62, 87, 88, 90, 91,
317, 383 93, 131, 188, 269, 275, 289, 293, 323, 333, 334,
idiopathic, 3, 4, 6, 9, 10, 42, 52, 60, 164, 166, 192, 348, 353, 393
INF, 29, 47, 236
193, 229, 243, 245, 246, 247, 266, 272, 369, 370, infants, 20, 34, 50, 129
371, 372, 373 infarction, 35, 36, 38, 40, 45, 58, 162, 181, 208, 209,
idiopathic thrombocytopenic purpura, 246 210, 211, 212, 215, 253, 277, 278, 281, 284, 285,
idiosyncratic, 48 287, 289, 290, 291, 293, 337, 376, 377
IFN, 46, 97, 100, 105, 232, 233, 236, 237, 265, 353 infectious agents, 163, 201, 230
IFN?, 187, 314 infectious disorders, 156, 163
IL-17, 75, 88, 93, 186, 196 inferiority, 24
IL-8, 185 inflammasome, 97, 100
ILAR, 326 inflammatory bowel disease, 156, 159
illicit drug use, 266 inflammatory cells, 19, 27, 30, 34, 35, 38, 43, 100,
image(s), 156, 205, 211, 243, 247, 248, 249, 319, 103, 128, 167, 203, 247, 345, 376, 377
320, 357, 378 inflammatory disease, 102, 132, 139, 154, 173, 190,
image analysis, 156 212, 283, 347, 349
imaging modalities, 150 inflammatory mechanisms, vii
IMAP, 106 inflammatory mediators, 99
immune activation, 264 inflammatory responses, 99, 104
immune function, 74, 96 infliximab, 47, 48, 57, 293, 305, 308, 309, 324
immune response, 75, 86, 87, 88, 90, 91, 92, 94, 97, influenza, 57, 169
99, 182 influenza meningitis, 57
immune system, vii, 46, 47, 91, 92, 94, 97, 98, 103, ingestion, 25, 373
146, 177, 182, 189, 229 inheritance, 166
immunity, 31, 88, 90, 91, 196 inhibition, 46, 47, 48, 229, 335
immunization, 87, 88, 91 inhibitor, 29, 49, 63, 74, 87, 100, 103, 115, 187, 268,
immunocompromised, 38, 163, 169 324, 351
immunodeficiency, 39, 59, 91, 163, 221, 245, 397 initiation, 39, 43, 86, 88, 169, 189, 317, 320, 322
immunofixation, 46 injections, 53, 242, 351
immunofluorescence, 46, 153, 154, 155, 164, 183, injury, 36, 87, 88, 91, 122, 126, 134, 138, 177, 183,
253, 264, 351, 380, 392, 397 184, 195, 202, 261, 262, 267, 270, 298, 352, 354,
immunoglobulin(s), 28, 29, 45, 46, 54, 61, 62, 98, 376, 393
101, 103, 121, 130, 134, 135, 141, 150, 228, 286, innate immunity, 98, 100, 104, 106, 146
351, 363, 367, 386, 395 inner ear, 137, 180, 190
immunoglobulin superfamily, 98 inositol, 100, 185
immunologist, 53 insertion, 102, 117, 282
immunomodulation, 46 insomnia, 35
immunomodulatory, 106, 227, 236 insulin, 46, 69
immunosuppression, 29, 214, 216, 218, 219, 270, integration, 284, 311
277, 290, 308, 390 integrin(s), 103, 184, 194, 195
immunosuppressive agent, 61, 289 intensive care unit, 215, 216, 224
immunosuppressive drugs, 304 intercellular adhesion molecule, 98
immunosuppressive therapies, 86 interface, 370, 371, 372, 374, 381
improvements, 238, 299 interference, 90
in vitro, 112, 188
in vivo, vii, 43, 92, 94, 193, 194, 380

Complimentary Contributor Copy